Overlooked or underestimated risk factors may warrant more consideration in stroke prevention and epidemiology, according to ...
Stroke during pregnancy or shortly after delivery is rare, yet it can be life-threatening. Increased awareness and ...
A new scientific statement from the American Heart Association outlines maternal stroke risk and prevention and treatment strategies during pregnancy and postpartum.
More than 795,000 people in the U.S. have a stroke each year, which is a leading cause of serious long-term disability. Many of the leading risk factors for stroke are modifiable, making prevention ...
Stroke Prevention 2.0 focuses on early detection of hidden risks like atrial fibrillation, inflammation, and structural heart defects.
Women who follow the Mediterranean diet have a lower risk of stroke, especially ischemic and hemorrhagic types, according to ...
Asundexian cut the risk of an additional stroke by 26% in a large Phase 3 trial without accompanying safety issues, boosting the commercial outlook for an emerging class of anti-clotting drugs.
An investigational anti-clotting medication, asundexian, has demonstrated a reduction in the risk of a second ischemic ...
FRANKFURT, Feb 5 (Reuters) - Bayer said on Thursday its experimental blood thinner cut the risk of stroke recurrence by 26% ...
The rationale behind the treatment is that because genetic FXI deficiency has been linked with reduced risk of ischemic ...
Bayer today presented the results from the global, pivotal Phase III OCEANIC-STROKE study evaluating the use of its ...
Bayer has linked asundexian to a 26% reduction in stroke in a phase 3 study, setting the bar for Bristol Myers Squibb and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results